MARKER THERAPEUTICS Trademark

Trademark Overview

On Tuesday, March 13, 2018, a trademark application was filed for MARKER THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MARKER THERAPEUTICS trademark a serial number of 87832107. The federal status of this trademark filing is REGISTERED as of Tuesday, September 17, 2024. This trademark is owned by Marker Therapeutics, Inc.. The MARKER THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

T-cell pharmaceutical products for the treatment of cancer

Biotechnology services, namely, the development of T-cell pharmaceutical products and technologies for use in the treatment of cancer
marker therapeutics

General Information

Serial Number87832107
Word MarkMARKER THERAPEUTICS
Filing DateTuesday, March 13, 2018
Status700 - REGISTERED
Status DateTuesday, September 17, 2024
Registration Number7507827
Registration DateTuesday, September 17, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2021

Trademark Statements

Goods and ServicesT-cell pharmaceutical products for the treatment of cancer
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesBiotechnology services, namely, the development of T-cell pharmaceutical products and technologies for use in the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 20, 2018
Primary Code005
First Use Anywhere DateWednesday, October 17, 2018
First Use In Commerce DateMonday, August 28, 2023
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 20, 2018
Primary Code042
First Use Anywhere DateWednesday, October 17, 2018
First Use In Commerce DateWednesday, October 17, 2018

Trademark Owner History

Party NameMarker Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brighton, MN 55112
Party NameMarker Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brighton, MN 55112
Party NameMarker Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brighton, MN 55112

Trademark Events

Event DateEvent Description
Saturday, June 30, 2018NON-FINAL ACTION E-MAILED
Friday, March 16, 2018NEW APPLICATION ENTERED
Tuesday, March 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 24, 2018ASSIGNED TO EXAMINER
Saturday, June 30, 2018NON-FINAL ACTION WRITTEN
Saturday, June 30, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 24, 2019NON-FINAL ACTION WRITTEN
Thursday, January 24, 2019NON-FINAL ACTION E-MAILED
Thursday, January 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 24, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 24, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 27, 2020FINAL REFUSAL WRITTEN
Wednesday, September 18, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2019NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 27, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, April 27, 2020FINAL REFUSAL E-MAILED
Monday, April 27, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 27, 2020EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, October 27, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, October 27, 2020EX PARTE APPEAL-INSTITUTED
Thursday, December 10, 2020ATTORNEY REVIEW COMPLETED
Thursday, December 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 11, 2020ASSIGNED TO LIE
Friday, December 11, 2020EXPARTE APPEAL TERMINATED
Wednesday, December 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, January 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, September 16, 2021SOU EXTENSION 1 GRANTED
Tuesday, March 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 16, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 16, 2021SOU EXTENSION 1 FILED
Thursday, March 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 15, 2022SOU EXTENSION 2 FILED
Tuesday, March 15, 2022SOU EXTENSION 2 GRANTED
Monday, September 12, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 12, 2022SOU EXTENSION 3 FILED
Monday, September 12, 2022SOU EXTENSION 3 GRANTED
Wednesday, September 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 10, 2023SOU EXTENSION 4 FILED
Friday, March 10, 2023SOU EXTENSION 4 GRANTED
Tuesday, March 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 5 FILED
Friday, September 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 22, 2023SOU EXTENSION 5 GRANTED
Friday, March 15, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, September 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2024USE AMENDMENT FILED
Friday, April 5, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 5, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 13, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 17, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 17, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics marker cell treatment cancer products pharmaceutical development technologies services biotechnology namely